
The first drug approved in the United States to treat thyroid eye disease may come with an unwelcome side effect for many: A small, new study finds that up to two-thirds of patients who take the medication experience hearing problems. Teprotumumab (Tepezza) was approved by the U.S. Food and Drug Administration in January 2020. In… read on > read on >